Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
14.95
+0.16 (1.08%)
Mar 24, 2026, 10:04 AM CST
SHA:600161 Market Cap
SHA:600161 has a market cap or net worth of 29.25 billion as of March 23, 2026. Its market cap has decreased by -25.79% in one year.
Market Cap
29.25B
Enterprise Value
31.06B
Revenue
6.42B
Ranking
n/a
PE Ratio
22.42
Stock Price
14.95
Market Cap Chart
Since March 8, 2000, SHA:600161's market cap has increased from 3.95B to 29.25B, an increase of 640.85%. That is a compound annual growth rate of 7.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 29.25B | -9.49% |
| Dec 31, 2025 | 32.31B | -20.29% |
| Dec 31, 2024 | 40.54B | -20.49% |
| Dec 29, 2023 | 50.98B | 30.38% |
| Dec 30, 2022 | 39.10B | -1.67% |
| Dec 31, 2021 | 39.77B | -23.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharmaron Beijing | 44.52B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 43.28B |
| Shanghai Allist Pharmaceuticals | 40.60B |
| Shanghai RAAS Blood Products | 39.76B |
| Chongqing Zhifei Biological Products | 37.49B |
| Hebei Changshan Biochemical Pharmaceutical | 35.18B |
| Asymchem Laboratories (Tianjin) | 31.53B |
| Xiamen Amoytop Biotech | 27.21B |